JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Liposome encapsulated polydopamine nanoparticles: Enhancing ferroptosis and activating hypoxia prodrug activity

  • 0The Higher Educational Key Laboratory for Biomedical Engineering of Fujian Province, Fujian Key Laboratory of Surface and Interface Engineering for High Performance Materials, Department of Biomaterials, College of Materials, Xiamen University, Xiamen 361005, Fujian, China.
Materials Today. Bio +

|

March 6, 2024

|

March 6, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

This study introduces novel nanoliposomes that enhance ferroptosis therapy by improving reactive oxygen species utilization and promoting tumor hypoxia. This synergistic approach combines enhanced ferroptosis with chemotherapy for effective cancer treatment.

Area Of Science

  • Biomedical Engineering
  • Nanotechnology
  • Cancer Therapy

Background

  • Ferroptosis therapy is limited by the short lifespan of reactive oxygen species and low oxygen levels in tumors.
  • Improving the real-time utilization of active oxygen species is crucial for effective anticancer treatment.

Purpose Of The Study

  • To develop a novel nanoliposome system (Lip@PDA-Fe-TPZ) to overcome the limitations of traditional ferroptosis therapy.
  • To achieve synergistic tumor killing by combining enhanced ferroptosis with hypoxia-activated chemotherapy.

Main Methods

  • Synthesized tirapazamine (TPZ)-loaded polydopamine-Fe nanoparticles (PDA-Fe-TPZ) and modified them with unsaturated liposomes (Lip).
  • Investigated the reaction of Lip@PDA-Fe-TPZ nanoliposomes with H2O2 via Fenton reaction to generate hydroxyl radicals (•OH).
  • Evaluated the role of liposomes in enhancing lipid peroxidation, oxygen consumption, and hypoxia induction.

Main Results

  • The nanoliposomes effectively reacted with H2O2 to produce •OH, which was stabilized by liposomes, preventing its annihilation.
  • Liposomes enhanced lipid peroxidation and promoted oxygen consumption, leading to increased tumor hypoxia.
  • Hypoxia triggered TPZ release and activation in tumor cells, leading to synergistic ferroptosis and chemotherapy.

Conclusions

  • The developed Lip@PDA-Fe-TPZ nanoliposomes offer a promising strategy for enhancing ferroptosis therapy.
  • The combination of enhanced ferroptosis and hypoxia-activated chemotherapy provides an efficient and specific tumor-killing effect.
  • This approach represents a potential future treatment for cancer.

Keywords: